DTC Testing - Power & Pitfalls - Dr. Fran Kendall - 4/5/19

June 08, 2020 01:02:14
DTC Testing - Power & Pitfalls - Dr. Fran Kendall - 4/5/19
MitoAction Expert Series
DTC Testing - Power & Pitfalls - Dr. Fran Kendall - 4/5/19

Jun 08 2020 | 01:02:14

/

Show Notes

Join MitoAction and Dr. Frank Kendall to discuss Direct to Consumer genetic testing (DTC testing) in detail. Some talking points will include:

About The Speaker:

Dr. Fran Kendall is one of the pioneers in the field and is a Harvard-trained board-certified Clinical Biochemical Geneticist who founded the very first clinical mitochondrial disease program in the United States. Over decades of a career specializing in Metabolic, Mitochondrial, and Inherited Disorders, she: founded one of the first commercial laboratories focused on rare metabolic and mitochondrial disorders; pioneered telemedicine and private practice in rare genetics by founding VMP Genetics which has branched into 3 divisions (Direct Patient Care, Education, Physician to Physician Support); was the head of genetics for a large hospital system; authored chapters on mitochondrial medicine for medical texts and numerous research articles; lectures at medical schools and nursing schools on these disorders; is a frequent guest speaker at medical conferences on mitochondrial disease and autism; often acts as an expert witness in Federal court cases; and has appeared on national news outlets to offer expert opinion.

She currently sees children and adult patients from around the world in either her VMP Genetics clinic offices in Atlanta, GA or by telemedicine.

Other Episodes

Episode 0

February 14, 2021 00:44:59
Episode Cover

Patients as Partners in Drug Development - Dr. Madhu Davies - 2/12/21

Join MitoAction and Dr. Madhu Davies from Reneo Pharmaceuticals for our February Monthly Mito Expert Series titled “Patients as Partners in Drug Development.” About...

Listen

Episode

January 28, 2026 00:39:28
Episode Cover

Understanding TK2d and the KYGEVVI Approval

Join us for an informative webinar exploring KYGEVVI™ (doxecitine and doxribtimine), the first FDA-approved treatment for thymidine kinase 2 deficiency (TK2d) in adults and...

Listen

Episode

June 23, 2022 00:46:33
Episode Cover

9 Tips to Ensure Your Insurer Pays Up

Frustrated with the run-around from health insurance companies? Join us this month as we discuss strategies for advocating for the diagnosis, management, and treatment...

Listen